Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial.
Ricart M, Bonacina E, Garcia-Manau P, López M, Caamiña S, Vives À, Lopez-Quesada E, Maroto A, de Mingo L, Pintado E, Ferrer-Costa R, Martín L, Rodriguez-Zurita A, Garcia E, Pallarols M, Pratcorona L, Teixidor M, Orizales-Lago C, Ocaña V, Del Barco E, Carreras E, Suy A, Mendoza M.
Ricart M, et al. Among authors: mendoza m.
Acta Obstet Gynecol Scand. 2024 Aug 22. doi: 10.1111/aogs.14955. Online ahead of print.
Acta Obstet Gynecol Scand. 2024.
PMID: 39171611